Advertisement

ADVERTISEMENT

Videos

Benjamin Besse, MD, PhD
Videos
First-Line Amivantamab Plus Lazertinib Demonstrates Promise in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer
10/28/2024
Benjamin Besse, MD, PhD, discusses early analysis results from the MARIPOSA study which demonstrated that amivantamab plus lazertinib has promising antitumor activity in patients with advanced EGFR-mutated NSCLC.
Benjamin Besse, MD, PhD, discusses early analysis results from the MARIPOSA study which demonstrated that amivantamab plus lazertinib has promising antitumor activity in patients with advanced EGFR-mutated NSCLC.
Benjamin Besse, MD, PhD,...
10/28/2024
APP Institute Oncology
Christoph Correll, MD.
Videos
Strategies to Manage Adverse Effects From Schizophrenia Treatment
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers...
10/28/2024
Psych Congress Network
Bruno Paiva, PhD
Conference Coverage
Exploring the Immune Microenvironment in Multiple Myeloma Treatment
10/25/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Bruno Paiva, PhD, shared expert insight into the immune determinants of response and resistance among patients with multiple myeloma, highlighting the need to bring immune biomarkers into the...
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Bruno Paiva, PhD, shared expert insight into the immune determinants of response and resistance among patients with multiple myeloma, highlighting the need to bring immune biomarkers into the...
At the 2024 Lymphoma, Leukemia &...
10/25/2024
Lymphoma, Leukemia & Myeloma Network
Jonathan Canaani, MD
Conference Coverage
Advances in Risk Stratification and Treatment for Patients With AML
10/24/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Jonathan Canaani, MD, discusses advancements in risk stratification and prognosis among patients with acute myeloid leukemia.
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Jonathan Canaani, MD, discusses advancements in risk stratification and prognosis among patients with acute myeloid leukemia.
At the 2024 Lymphoma, Leukemia &...
10/24/2024
Oncology
Joseph Mikhael, MD
Conference Coverage
Treatment Options for When Immune Therapies Fail Among Patients With R/R MM
10/24/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Joseph Mikhael, MD, discusses treatment possibilities for patients with 
R/R multiple myeloma when immune therapies, such as antibody drug conjugates, CAR T-cell therapy, and bispecific...
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Joseph Mikhael, MD, discusses treatment possibilities for patients with 
R/R multiple myeloma when immune therapies, such as antibody drug conjugates, CAR T-cell therapy, and bispecific...
At the 2024 Lymphoma, Leukemia &...
10/24/2024
Lymphoma, Leukemia & Myeloma Network
John Leonard, MD
Videos
Highlights in Indolent Lymphomas From the LL&M Congress
10/23/2024
In part 1 of this expert roundtable covering updates in lymphoma from the 2024 Lymphoma, Leukemia & Myeloma Congress, John Leonard, MD, discusses research in indolent lymphomas, highlighting follicular lymphomas, with Matthew Lunning, DO,...
In part 1 of this expert roundtable covering updates in lymphoma from the 2024 Lymphoma, Leukemia & Myeloma Congress, John Leonard, MD, discusses research in indolent lymphomas, highlighting follicular lymphomas, with Matthew Lunning, DO,...
In part 1 of this expert...
10/23/2024
Lymphoma, Leukemia & Myeloma Network
The Frank & Lizzie Show Episode 22
Sponsored Video
The Frank & Lizzie Show: Episode 22: Mirragen: The Future of Wound Care – An Inside Look with ETS
10/23/2024
The Frank & Lizzie Show interviewed Dr Steve Jung, PhD, Chief Technology Office, and AJ Ford, CEO of Engineered Tissue Solutions (ETS) on their revolutionary product, Mirragen, LIVE from SAWC Fall in Las Vegas. Dr Jung walks Frank & Lizzie...
The Frank & Lizzie Show interviewed Dr Steve Jung, PhD, Chief Technology Office, and AJ Ford, CEO of Engineered Tissue Solutions (ETS) on their revolutionary product, Mirragen, LIVE from SAWC Fall in Las Vegas. Dr Jung walks Frank & Lizzie...
The Frank & Lizzie Show...
10/23/2024
Wounds
Andrea Necchi, MD
Conference Coverage
TAR-200 Plus Cetrelimab Provides Promising Clinical Benefit for Patients With Muscle-Invasive Bladder Cancer
10/23/2024
Andrea Necchi, MD, discusses results from the SunRISe-4 study which assessed the addition of TAR-200 to neoadjuvant cetrelimab in a cohort of patients with muscle-invasive bladder cancer who either refused or were ineligible for...
Andrea Necchi, MD, discusses results from the SunRISe-4 study which assessed the addition of TAR-200 to neoadjuvant cetrelimab in a cohort of patients with muscle-invasive bladder cancer who either refused or were ineligible for...
Andrea Necchi, MD, discusses...
10/23/2024
Oncology
Alexey Danilov, MD
Conference Coverage
Exciting Developments and Novel Targets in Chronic Lymphocytic Leukemia Treatment
10/21/2024
Alexey Danilov, MD, reviews the latest exciting developments in the chronic lymphocytic leukemia clinical research landscape, highlighting BTK and BCL2 inhibitors as well as BTK degraders.
Alexey Danilov, MD, reviews the latest exciting developments in the chronic lymphocytic leukemia clinical research landscape, highlighting BTK and BCL2 inhibitors as well as BTK degraders.
Alexey Danilov, MD, reviews the...
10/21/2024
Oncology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Dermatology Week
November 13 ⁠–⁠ November 16
Derm Week
November 13 ⁠–⁠ November 16
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use